Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
3
×
wisconsin blog main
wisconsin top stories
democrats
gene therapy
immunomedics
ipo
sma
spinal muscular atrophy
venture capital
2025
accent therapeutics
What
bio
ipo
3
×
roundup
3
×
biogen
new
activity
allogene
america
approvals
cancer
clamped
continues
convoluted
covid
crispr
delays
democrats
developing
diversity
dreams
economic
fast
fda
head
headaches
healthcare
holding
hot
immunotherapy
including
insurance
investors
isn’t
juno
lot
medicines
million
moves
nearly
oric’s
Language
unset
Current search:
ipo
×
roundup
×
" new york blog main "
×
vc
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More